Issues pertaining to Medicare reimbursement. Legislation regarding the 340B Drug
discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI demonstration
(OCM/OCF)
Issues related to pharmacy benefit managers. TACT Act
Legislation regarding the 340B Drug discount program. Issues related to pharmacy benefit managers. Drug Pricing legislation. 21st Century Cures 2.0
Duration: January 1, 2016
to
present
General Issues: Medicare/Medicaid , Pharmacy , Health Issues , Veterans
Spending: about $2,550,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2016: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Jeff MacKinnon
LD and LA Rep. Joe Barton (R-Texas)
LD & LA Rep. Joe Barton (RTexas)
Jeff Mortier
Prof Staff on E&C Cmte and LA Rep Whitfield
Prof Staff on E&C Cmte, LA Rep Whitfield and Intern
Devin Nunes
Joseph Vasapoli
Min.Counsel, Energy&Comm, Special Asst. DOE
Min. Counsel, Energy&Comm, Special Asst. DOE
Jeffery Mortier
Prof Staff on E&C Cmte and LA Rep Whitfield, Intern for Devin Nunes
Prof Staff on E&C Cmte, LA Rep Whitfield and Intern
Devin Nunes
Prof Staff on E&C Cmte, LA Rep Whitfield and Intern Devin Nunes
Jeffrey MacKinnon
LD and LA Rep. Joe Barton (R-Texas)
Sarah Walter
Former Legislative Director/Chief Counsel, Sen. John Breaux
J. Daniel Walsh
LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner
Edward Whitfield
U.S. Representative (21 yrs.)
Member of Congress (KY 01), 21 yrs.
Dan Walsh
LD Rep. Wayne Gilchrest and LA Rep. Jack Buechner
Kristen O'Neill
Health Policy Advisory, LA, Staff Assistant Gene Greene (D-TX)
Staff Assistant GK Butterfield (D-NC)
Health Policy Advisory, LA, Staff Assistant Gene Greene (DTX) Staff Assistant GK Butterfield (D-NC)
Kristen Bautz
Senior Advisor and Special Projects Coordinator, Rep Wasserman Shultz
Dylan Moore
Intern/Staff Assistant, Speaker John Boehner (OH-8); Legislative Assistant/Legislative Director/Deputy Chief of Staff, Rep. Larry Bucshon (IN-8)
Intern/Staff Assistant, Speaker John Boehner (OH-8); Legislative Assistant/Legislative Director/Deputy Chief of Staff, Rep. Larry Bucshon (IN-8); Intern, Rep. Mike Turner (OH-10)
Jody Gale
n/a
William Krieger
n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on April 19.
Original Filing: 301566517.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Legislation regarding the 340B Drug
discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI demonstration
(OCM/OCF)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to pharmacy benefit managers. TACT Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislation regarding the 340B Drug discount program. Issues related to pharmacy benefit managers. Drug Pricing legislation. 21st Century Cures 2.0
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2023
In Q4, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on Jan. 22.
Original Filing: 301539371.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Legislation regarding the 340B Drug
discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI demonstration
(OCM/OCF)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to pharmacy benefit managers. TACT Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislation regarding the 340B Drug discount program. Issues related to pharmacy benefit managers. Drug Pricing legislation. 21st Century Cures 2.0
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2023
In Q3, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on Oct. 20, 2023.
Original Filing: 301513961.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Legislation regarding the 340B Drug
discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI demonstration
(OCM/OCF)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to pharmacy benefit managers. TACT Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislation regarding the 340B Drug discount program. Issues related to pharmacy benefit managers. Drug Pricing legislation. 21st Century Cures 2.0
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2023
In Q2, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on July 20, 2023.
Original Filing: 301489526.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Legislation regarding the 340B Drug
discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI demonstration
(OCM/OCF)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to pharmacy benefit managers. TACT Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislation regarding the 340B Drug discount program. Issues related to pharmacy benefit managers. Drug Pricing legislation. 21st Century Cures 2.0
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2023
In Q1, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on April 20, 2023.
Original Filing: 301462274.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Legislation regarding the 340B Drug
discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI demonstration
(OCM/OCF)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to pharmacy benefit managers. TACT Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislation regarding the 340B Drug discount program. Issues related to pharmacy benefit managers. Drug Pricing legislation. 21st Century Cures 2.0
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2022
In Q4, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on Jan. 20, 2023.
Original Filing: 301442261.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Legislation regarding the 340B Drug
discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI demonstration (OCM/OCF)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to pharmacy benefit managers. HR 3258 TACT Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislation regarding the 340B Drug discount program. Issues related to pharmacy benefit managers. Drug Pricing legislation. 21st Century Cures 2.0
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2022
In Q3, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on Oct. 20, 2022.
Original Filing: 301415870.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Legislation regarding the 340B Drug
discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI demonstration (OCM/OCF)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to pharmacy benefit managers. HR 3258 TACT Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislation regarding the 340B Drug discount program. Issues related to pharmacy benefit managers. Drug Pricing legislation. 21st Century Cures 2.0
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2022
In Q2, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on July 20, 2022.
Original Filing: 301395951.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Legislation regarding the 340B Drug
discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI demonstration (OCM/OCF)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to pharmacy benefit managers. HR 3258 TACT Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislation regarding the 340B Drug discount program. Issues related to pharmacy benefit managers. Drug Pricing legislation. 21st Century Cures 2.0
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2022
In Q1, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on April 20, 2022.
Original Filing: 301369328.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Legislation regarding the 340B Drug
discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI demonstration (OCM/OCF)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to pharmacy benefit managers. HR 3258 TACT Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislation regarding the 340B Drug discount program. Issues related to pharmacy benefit managers. Drug Pricing legislation. 21st Century Cures 2.0
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2021
In Q4, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on Jan. 20, 2022.
Original Filing: 301336663.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Legislation regarding the 340B Drug
discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI demonstration (OCM/OCF)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to pharmacy benefit managers. HR 3258 TACT Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislation regarding the 340B Drug discount program. Issues related to pharmacy benefit managers. Drug Pricing legislation. 21st Century Cures 2.0
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2021
In Q3, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on Oct. 20, 2021.
Original Filing: 301310975.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Legislation regarding the 340B Drug
discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI demonstration (OCM/OCF)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to pharmacy benefit managers. HR 3258 TACT Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislation regarding the 340B Drug discount program. Issues related to pharmacy benefit managers. Drug Pricing legislation. 21st Century Cures 2.0
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2021
In Q2, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on July 14, 2021.
Original Filing: 301276003.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Legislation regarding the 340B Drug
discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI demonstration (OCM/OCF)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to pharmacy benefit managers. HR 3258 TACT Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Legislation regarding the 340B Drug discount program. Issues related to pharmacy benefit managers. Drug Pricing legislation. 21st Century Cures 2.0
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2021
In Q1, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on April 20, 2021.
Original Filing: 301262750.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug
discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI Guardrails
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to pharmacy benefit managers
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug
discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. Issues related to
COVID-19 stimulus legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2020
In Q4, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on Jan. 19, 2021.
Original Filing: 301236431.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI Guardrails
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. Issues related to COVID-19 stimulus legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2020
In Q3, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on Oct. 19, 2020.
Original Filing: 301215629.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI Guardrails
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. Issues related to COVID-19 stimulus legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
2nd Quarter, 2020
In Q2, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on July 20, 2020.
Original Filing: 301198087.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI Guardrails
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. Issues related to COVID-19 stimulus legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2020
Farragut Partners LLP amended a lobbying report for representation of Community Oncology Alliance in Q12020 on April 20, 2020.
Original Filing: 301173792.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI Guardrails
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. Issues related to COVID-19 stimulus legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2020
In Q1, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on April 13, 2020.
Original Filing: 301165886.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI Guardrails
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
4th Quarter, 2019
Farragut Partners LLP amended a lobbying report for representation of Community Oncology Alliance in Q42019 on Jan. 22, 2020.
Original Filing: 301129986.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI Guardrails
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
4th Quarter, 2019
Farragut Partners LLP amended a lobbying report for representation of Community Oncology Alliance in Q42019 on Jan. 22, 2020.
Original Filing: 301129817.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI Guardrails
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
4th Quarter, 2019
In Q4, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on Jan. 17, 2020.
Original Filing: 301109448.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI Guardrails
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
3rd Quarter, 2019
Farragut Partners LLP amended a lobbying report for representation of Community Oncology Alliance in Q32019 on Jan. 22, 2020.
Original Filing: 301129820.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI Guardrails
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
3rd Quarter, 2019
In Q3, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on Oct. 18, 2019.
Original Filing: 301069365.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI Guardrails
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
2nd Quarter, 2019
In Q2, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on July 18, 2019.
Original Filing: 301049176.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Type of Issue
Medicare/Medicaid Health Issues
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
1st Quarter, 2019
In Q1, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on April 17, 2019.
Original Filing: 301026950.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration Issues related to pharmacy benefit managers. Drug pricing legislation- ASP reform proposals.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Type of Issue
Medicare/Medicaid Health Issues
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
1st Quarter, 2019
Farragut Partners LLP amended a lobbying report for representation of Community Oncology Alliance in Q12019 on April 17, 2019.
Original Filing: 301026961.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration; H.R. 1934 Cancer Care Payment Reform Act. Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Type of Issue
Medicare/Medicaid Health Issues
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
4th Quarter, 2018
In Q4, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on Jan. 16, 2019.
Original Filing: 301005241.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration H.R. 1934 Cancer Care Payment Reform Act. Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Type of Issue
Medicare/Medicaid Health Issues
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues relating to VA claw back on reimbursements for community providers
Agencies Lobbied
U.S. Senate U.S. House of Representatives Veterans Affairs - Dept of (VA)
3rd Quarter, 2018
In Q3, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on Oct. 18, 2018.
Original Filing: 300989095.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration H.R. 1934 Cancer Care Payment Reform Act. Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Type of Issue
Medicare/Medicaid Health Issues
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues relating to VA claw back on reimbursements for community providers
Agencies Lobbied
U.S. Senate U.S. House of Representatives Veterans Affairs - Dept of (VA)
2nd Quarter, 2018
In Q2, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on July 19, 2018.
Original Filing: 300971397.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration H.R. 1934 Cancer Care Payment Reform Act. Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Type of Issue
Medicare/Medicaid Health Issues
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues relating to VA claw back on reimbursements for community providers
Agencies Lobbied
U.S. Senate U.S. House of Representatives Veterans Affairs - Dept of (VA)
1st Quarter, 2018
In Q1, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on April 18, 2018.
Original Filing: 300947573.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration H.R. 1934 Cancer Care Payment Reform Act. Issues related to pharmacy benefit managers. HR 1920 Prompt Pay legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Type of Issue
Medicare/Medicaid Health Issues
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Issues relating to VA claw back on reimbursements for community providers
Agencies Lobbied
U.S. Senate U.S. House of Representatives Veterans Affairs - Dept of (VA)
4th Quarter, 2017
In Q4, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on Jan. 11, 2018.
Original Filing: 300922781.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration H.R. 1934 Cancer Care Payment Reform Act. Issues related to pharmacy benefit managers. HR 1920 Prompt Pay legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Type of Issue
Medicare/Medicaid Health Issues
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
3rd Quarter, 2017
In Q3, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $80,000. The report was filed on Oct. 19, 2017.
Original Filing: 300909280.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration H.R. 1934 Cancer Care Payment Reform Act. Issues related to pharmacy benefit managers. HR 1920 Prompt Pay legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Type of Issue
Medicare/Medicaid Health Issues
Lobbying Issues
Issues related to pharmacy benefit managers.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
2nd Quarter, 2017
In Q2, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $70,000. The report was filed on July 20, 2017.
Original Filing: 300895948.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration H.R. 1934 Cancer Care Payment Reform Act. Medicare Part B Demonstration.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2017
In Q1, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $70,000. The report was filed on April 20, 2017.
Original Filing: 300877271.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration H.R. 1934 Cancer Care Payment Reform Act. Medicare Part B Demonstration
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2016
In Q4, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $70,000. The report was filed on Jan. 23, 2017.
Original Filing: 300857666.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration H.R. 1934 Cancer Care Payment Reform Act. Medicare Part B Demonstration
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2016
In Q3, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $60,000. The report was filed on Oct. 20, 2016.
Original Filing: 300838904.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration H.R. 1934 Cancer Care Payment Reform Act. Medicare Part B Demonstration
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2016
In Q2, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $60,000. The report was filed on July 20, 2016.
Original Filing: 300819511.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration H.R. 1934 Cancer Care Payment Reform Act. Medicare Part B Demonstration
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2016
Farragut Partners LLP filed a lobbying registration on Nov. 7, 2017 to represent Community Oncology Alliance, effective Jan. 1, 2016.
Original Filing: 300918919.xml
Issue(s) they said they’d lobby about: Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration. .
1st Quarter, 2016
In Q1, Farragut Partners LLP lobbied for Community Oncology Alliance , earning $60,000. The report was filed on April 20, 2016.
Original Filing: 300801979.xml
Lobbying Issues
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount
program. Issues pertaining to sequestration H.R. 1934 Cancer Care Payment Reform Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2016
Farragut Partners LLP filed a lobbying registration on Feb. 12, 2016 to represent Community Oncology Alliance, effective Jan. 1, 2016.
Original Filing: 300786518.xml
Issue(s) they said they’d lobby about: Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, monitoring legislation regarding the 340B Drug discount program. Issues pertaining to sequestration. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate